MSAC clears path for Hep D antiviral
By Megan Brodie 1 year ago | In Companies, MedTech, Products, Reimbursement- 1 year ago
28 July 2025 MSAC has supposedly cleared the path for the PBAC to recommend the…
This is subscriber-only content. Please login to continue reading.